Related by context. Frequent words. (Click for all words.) 84 Phase Ib 81 Phase 2a 79 Phase 2b study 78 Phase IIa 78 Phase 2b trial 77 Phase IIb 76 Phase 2a clinical 76 Phase III 76 Phase 2b 75 pivotal Phase III 75 Phase II 75 Phase 2b clinical 74 Phase IIa clinical 74 Phase IIb clinical 74 dose escalation study 74 Phase IIa trial 74 randomized Phase 73 Phase III clinical 73 dose escalation 72 Phase IIb trial 72 pivotal Phase 70 Phase 67 RDEA# 67 initiate Phase 67 Phase III clinical trials 66 XL# [003] 66 ofatumumab 66 placebo controlled 66 PRX # 66 tolerability 65 IDX# 65 ISIS # 65 RG# [001] 65 LEVADEX 64 IMGN# 64 perifosine 64 ARRY 64 unblinded 63 clinical trial 63 pharmacokinetic 63 carfilzomib 63 INCB# [002] 63 AP# [003] 63 MGCD# [001] 63 ASA# 63 safety tolerability 63 CYT# 63 HspE7 63 AEZS 63 randomized placebo controlled 62 Phase III trials 62 laquinimod 62 pharmacodynamic 62 eculizumab 62 preclinical 62 voreloxin 62 blind randomized placebo 62 evaluable patients 62 MDV# 62 ALKS 61 preclinical studies 61 T DM1 61 pharmacokinetic profile 61 pharmacodynamics 61 picoplatin 61 LymphoStat B 61 Marqibo 61 CRx 61 daclizumab 61 mipomersen 61 tivozanib 61 double blind placebo 61 randomized double 61 multicenter 61 investigational compound 61 monotherapy 60 Locteron 60 randomized controlled 60 FOLOTYN 60 pharmacokinetics 60 antitumor activity 60 humanized monoclonal antibody 60 DSMB 60 ITMN 60 PMX # 59 bavituximab 59 ACTEMRA 59 tolerability profile 59 randomized clinical 59 NDA submission 59 ENMD 59 Defibrotide 59 antiviral activity 59 blind placebo controlled 59 oral formulation 59 Tovaxin 58 relapsing remitting multiple sclerosis 58 sunitinib 58 ANA# 58 avanafil 58 randomized